New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid

The current treatment for drug-resistant tuberculosis (TB) is long, complex, and associated with severe and life-threatening side effects and poor outcomes. For the first time in nearly 50 years, there have been two new drugs registered for use in multidrug-resistant TB (MDR-TB). Bedaquiline, a diar...

Full description

Saved in:
Bibliographic Details
Published in:Infect Drug Resist
Main Authors: Brigden, Grania, Hewison, Cathy, Varaine, Francis
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2015
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4634826/
https://ncbi.nlm.nih.gov/pubmed/26586956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S68351
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items